SCHEMBL6674610

SCHEMBL6674610

CN1CCCC1CCOc1cc(Cl)ccc1Cc1cnn(C)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRNB4 P30926 4/20 0.41
CHRNA3 P32297 4/20 0.41
CHRNB1 P11230 3/20 0.41
CHRNB2 P17787 3/20 0.41
CHRNB3 Q05901 3/20 0.41
CHRNA7 P36544 1/20 0.41
CHRM3 P20309 4/20 0.41
ADRA1A P35348 2/20 0.41
HRH1 P35367 2/20 0.41
HRH3 Q9Y5N1 2/20 0.41
SLC22A1 O15245 1/20 0.41
MLNR O43193 1/20 0.41
NR1I2 O75469 1/20 0.41
TP53 P04637 1/20 0.41
ADRB2 P07550 1/20 0.41
CHRM2 P08172 1/20 0.41
CHRM4 P08173 1/20 0.41
ADRB1 P08588 1/20 0.41
CYP3A4 P08684 1/20 0.41
HTR1A P08908 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6652803 0.98 CHRNB4 (0.40) CHRNB4CHRNA3CHRNB1CHRNB2CHRNB3
SCHEMBL6649785 0.88 TSHR (0.42) CYP2D6CHRM1CYP2C9DRD2TSHR
SCHEMBL6655668 0.87 TSHR (0.37) ADRA1AHRH1HRH3CYP2D6CHRM1
SCHEMBL6675842 0.76 PDE4D (0.42) CHRNB2KCNH2KDRCHRNA4
SCHEMBL11448375 0.73 CHRM3 (0.48) CHRNB4CHRNA3CHRNB2CHRNA7CHRM3
SCHEMBL11448596 0.71 CHRM3 (0.47) CHRNB4CHRNA3CHRNB2CHRNA7CHRM3
SCHEMBL14578283 0.71 LTA4H (0.54) CHRNB4CHRNA3CHRM3ADRA1AHRH1
SCHEMBL11449251 0.70 HRH3 (0.57) CHRNB4CHRNA3CHRNB1CHRNB2CHRNB3
SCHEMBL14578281 0.69 LTA4H (0.55) CHRNB4CHRNA3CHRM3ADRA1AHRH1
SCHEMBL11448416 0.69 LMNA (0.58) CHRNB4CHRNA3CHRNB2HRH3CHRNA4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1103243-B1 UTILIZATION OF ARYL(OR HETEROARYL)AZOLYLCARBINOL DERIVATIVES FOR THE TREATMENT OF TROUBLES MEDIATED BY AN EXCESS OF SUBSTANCE P ESTEVE LABOR DR (ES) 2004-01-07 EP claimed